Literature DB >> 15077146

Cell death by mitotic catastrophe: a molecular definition.

Maria Castedo1, Jean-Luc Perfettini, Thomas Roumier, Karine Andreau, Rene Medema, Guido Kroemer.   

Abstract

The current literature is devoid of a clearcut definition of mitotic catastrophe, a type of cell death that occurs during mitosis. Here, we propose that mitotic catastrophe results from a combination of deficient cell-cycle checkpoints (in particular the DNA structure checkpoints and the spindle assembly checkpoint) and cellular damage. Failure to arrest the cell cycle before or at mitosis triggers an attempt of aberrant chromosome segregation, which culminates in the activation of the apoptotic default pathway and cellular demise. Cell death occurring during the metaphase/anaphase transition is characterized by the activation of caspase-2 (which can be activated in response to DNA damage) and/or mitochondrial membrane permeabilization with the release of cell death effectors such as apoptosis-inducing factor and the caspase-9 and-3 activator cytochrome c. Although the morphological aspect of apoptosis may be incomplete, these alterations constitute the biochemical hallmarks of apoptosis. Cells that fail to execute an apoptotic program in response to mitotic failure are likely to divide asymmetrically in the next round of cell division, with the consequent generation of aneuploid cells. This implies that disabling of the apoptotic program may actually favor chromosomal instability, through the suppression of mitotic catastrophe. Mitotic catastrophe thus may be conceived as a molecular device that prevents aneuploidization, which may participate in oncogenesis. Mitotic catastrophe is controlled by numerous molecular players, in particular, cell-cycle-specific kinases (such as the cyclin B1-dependent kinase Cdk1, polo-like kinases and Aurora kinases), cell-cycle checkpoint proteins, survivin, p53, caspases and members of the Bcl-2 family.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15077146     DOI: 10.1038/sj.onc.1207528

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  406 in total

1.  Forced expression of the cyclin B1-CDC2 complex induces proliferation in adult rat cardiomyocytes.

Authors:  Katrina A Bicknell; Carmen H Coxon; Gavin Brooks
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

2.  Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model.

Authors:  Cheng-Huang Shen; Jia-Jen Shee; Jin-Yi Wu; Yi-Wen Lin; Jiann-Der Wu; Yi-Wen Liu
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 3.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

4.  Epigenetic reactivation of p21CIP1/WAF1 and KLOTHO by a combination of bioactive dietary supplements is partially ERα-dependent in ERα-negative human breast cancer cells.

Authors:  Sonam Sinha; Samriddhi Shukla; Sajid Khan; Trygve O Tollefsbol; Syed M Meeran
Journal:  Mol Cell Endocrinol       Date:  2015-02-25       Impact factor: 4.102

5.  Olig1 function is required for oligodendrocyte differentiation in the mouse brain.

Authors:  Jinxiang Dai; Kathryn K Bercury; Jared T Ahrendsen; Wendy B Macklin
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

6.  Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.

Authors:  Ana Vanessa Nascimento; Amit Singh; Hassan Bousbaa; Domingos Ferreira; Bruno Sarmento; Mansoor M Amiji
Journal:  Acta Biomater       Date:  2016-09-30       Impact factor: 8.947

7.  Induction of mitotic catastrophe by PKC inhibition in Nf1-deficient cells.

Authors:  Xiaodong Zhou; Sung-Hoon Kim; Ling Shen; Hyo-Jung Lee; Changyan Chen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  The 2,6-disubstituted purine reversine induces growth arrest and polyploidy in human cancer cells.

Authors:  Tze-Chen Hsieh; Frank Traganos; Zbigniew Darzynkiewicz; Joseph M Wu
Journal:  Int J Oncol       Date:  2007-12       Impact factor: 5.650

9.  Collaboration between hepatic and intratumoral prodrug activation in a P450 prodrug-activation gene therapy model for cancer treatment.

Authors:  Jie Ma; David J Waxman
Journal:  Mol Cancer Ther       Date:  2007-11-07       Impact factor: 6.261

10.  Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis.

Authors:  Anni I Nieminen; Vilja M Eskelinen; Heidi M Haikala; Topi A Tervonen; Yan Yan; Johanna I Partanen; Juha Klefström
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.